Analyst Conference Summaries

Biotechnology Investor Aids

Ionis Pharmaceuticals
IONS

conference date: August 7, 2018 @ 8:30 AM Pacific Time

Akcea Undervalued as Commercial Launches Near [April 12, 2018 @ Seeking Alpha]

Ionis is a Buy on RNA Platform Pipeline [March 7, 2018 @ Seeking Alpha]

2018
 
 
May 4, 2018
August 7, 2018
 
 
2017
Q1 not available
August 8, 2017
Nov. 7, 2017
Feb. 28, 2018

Ionis Pharmaceuticals (IONS) is a clinical-stage biotechnology company specializing in RNAi based therapies. Akcea Therapeutics (AKCA) is majority-owned by Ionis.

Ionis Pharmaceuticals web site

Ionis Pharmaceuticals investor relations


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 INO
 INTC
 ISRG
 JUNO
 MACK
 MCHP
 MYL.
 NVDA
 PLX
 REGN
 SGEN
 XLNX
 XLRN
 
 

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2018 William P. Meyers